Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: U.S. federal government appropriations via NIH | Statement: [NIDA Division of Therapeutics and Medical Consequences, fundingSource, U.S. federal government appropriations via NIH]

Target entity: U.S. federal government appropriations via NIH
Context triple: [NIDA Division of Therapeutics and Medical Consequences, fundingSource, U.S. federal government appropriations via NIH]

• A. NIH Common Fund
  The NIH Common Fund is a trans-NIH funding program that supports high-impact, innovative, and cross-cutting biomedical research initiatives that no single institute or center could tackle alone.
• B. National Institutes of Health intramural research program
  The National Institutes of Health intramural research program is a large, government-funded biomedical research enterprise in which NIH scientists conduct basic, translational, and clinical studies within NIH facilities.
• C. Center for Scientific Review
  The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
• D. NIH High-Risk, High-Reward Research program
  The NIH High-Risk, High-Reward Research program is a flagship National Institutes of Health initiative that supports exceptionally innovative and potentially transformative biomedical and behavioral research by funding investigators with bold, unconventional ideas.
• E. National Center for Advancing Translational Sciences
  The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: U.S. federal government appropriations via NIH
Triple: [NIDA Division of Therapeutics and Medical Consequences, fundingSource, U.S. federal government appropriations via NIH]

U.S. federal government appropriations via NIH are congressionally authorized funds allocated to the National Institutes of Health to support biomedical and public health research, including programs within institutes such as NIDA.

Target entity: U.S. federal government appropriations via NIH
Target entity description: U.S. federal government appropriations via NIH are congressionally authorized funds allocated to the National Institutes of Health to support biomedical and public health research, including programs within institutes such as NIDA.

• A. NIH Common Fund
  The NIH Common Fund is a trans-NIH funding program that supports high-impact, innovative, and cross-cutting biomedical research initiatives that no single institute or center could tackle alone.
• B. National Institutes of Health intramural research program
  The National Institutes of Health intramural research program is a large, government-funded biomedical research enterprise in which NIH scientists conduct basic, translational, and clinical studies within NIH facilities.
• C. Center for Scientific Review
  The Center for Scientific Review is the National Institutes of Health component responsible for overseeing the peer review of most grant applications to ensure scientific merit and integrity in funding decisions.
• D. NIH High-Risk, High-Reward Research program
  The NIH High-Risk, High-Reward Research program is a flagship National Institutes of Health initiative that supports exceptionally innovative and potentially transformative biomedical and behavioral research by funding investigators with bold, unconventional ideas.
• E. National Center for Advancing Translational Sciences
  The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
• F. None of above. chosen